Literature DB >> 8133909

The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators.

J P Wang1, S L Raung, C C Chen, J S Kuo, C M Teng.   

Abstract

In the present study, we demonstrated the inhibitory effect of magnolol on the plasma leakage in passive cutaneous anaphylactic (PCA) reaction, neurogenic inflammation, dorsal skin and ear edema in mice. Hind-paw skin plasma extravasation caused by antidromic stimulation of the saphenous nerve was reduced in mice pretreated with magnolol, diphenydramine or methysergide, but not with indomethacin. Ear edema formation in the PCA reaction was reduced by magnolol in dose-dependent manner. In addition, histamine-, serotonin-, compound 48/80-, bradykinin- and substance P-induced ear edema in mice was also suppressed by magnolol. A dose- and time-dependency of the inhibitory effect of magnolol was demonstrated in histamine- and compound 48/80-induced dorsal skin edema. The maximal inhibitory effect produced by a single dose of magnolol (10 mg/kg) persisted for 1 h, and significant suppression lasted for at least 3 h. In compound 48/80-pretreated mice, the histamine content of the ear was greatly reduced. Bradykinin- and substance P-induced ear edema in compound 48/80-pretreated mice was less severe than that seen in normal mice, but was still significantly reduced by magnolol pretreatment. Moreover, the inhibitory effect of magnolol was more marked than that of diphenhydramine combined with methysergide. These results suggest that the inhibitory effect of magnolol on local edema formation probably occurs through a nonselective inhibition on vascular tissue to prevent the permeability change caused by various mediators.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133909     DOI: 10.1007/bf00167245

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

1.  Intra-arterial injections of histamine, serotonin, or bradykinin: a topographic study of vascular leakage.

Authors:  G Gabbiani; M C Badonnel; G Majno
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

2.  Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells.

Authors:  T J Sullivan; C W Parker
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

3.  Inflammation induced by histamine, serotonin, bradykinin and compound 48-80 in the rat: antagonists and mechanisms of action.

Authors:  H M Maling; M E Webster; M A Williams; W Saul; W Anderson
Journal:  J Pharmacol Exp Ther       Date:  1974-11       Impact factor: 4.030

4.  Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin.

Authors:  N Jancsó; A Jancsó-Gábor; J Szolcsányi
Journal:  Br J Pharmacol Chemother       Date:  1967-09

5.  Modulation of acute inflammation by endogenous nitric oxide.

Authors:  A Ialenti; A Ianaro; S Moncada; M Di Rosa
Journal:  Eur J Pharmacol       Date:  1992-02-11       Impact factor: 4.432

6.  Tachykinin receptor subtype that mediates the increase in vascular permeability in guinea pig skin.

Authors:  I Iwamoto; J A Nadel
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

7.  Anti-inflammatory and analgesic effects of magnolol.

Authors:  J P Wang; M F Hsu; S L Raung; C C Chen; J S Kuo; C M Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

8.  Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge.

Authors:  A Saria; J M Lundberg; G Skofitsch; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

9.  Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells.

Authors:  R Morgan-Boyd; J M Stewart; R J Vavrek; A Hassid
Journal:  Am J Physiol       Date:  1987-10

10.  Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide.

Authors:  F Lembeck; J Donnerer; L Barthó
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

View more
  1 in total

Review 1.  Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders.

Authors:  Jui-Lung Shen; Kee-Ming Man; Po-Hsun Huang; Wen-Chi Chen; Der-Cherng Chen; Ya-Wen Cheng; Po-Len Liu; Ming-Chih Chou; Yung-Hsiang Chen
Journal:  Molecules       Date:  2010-09-16       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.